Method for treatment of atherosclerosis
    1.
    发明授权
    Method for treatment of atherosclerosis 失效
    治疗动脉粥样硬化的方法

    公开(公告)号:US5521201A

    公开(公告)日:1996-05-28

    申请号:US457387

    申请日:1995-06-01

    摘要: A method is provided for the treatment and/or prophylaxis of cardiovascular diseases in a human or non-human mammal, which comprises administering to a human or non-human mammal in need thereof, an effective, non-toxic amount of a compound of formula (I): ##STR1## or a tautomeric form thereof and/or a pharmaceuticlaly acceptable salt thereof and/or a pharmaceutically acceptable solvate thereof, in which A.sup.1 represents a substituted or unsubstituted aromatic heterocyclyl group; R.sup.1 represents a hydrogen atom, an alkyl group, an acyl group, an aralkyl group, wherein the aryl moiety may be substituted or unsubstituted, or a substituted or unsubstituted aryl group; R.sup.2 and R.sup.3 each represent hydrogen, or R.sup.2 and R.sup.3 together represent a bond; A.sup.2 represents a benzene ring having in total up to five substituents; and n represents an integer in the range of from 2 to 6.

    摘要翻译: 提供了用于治疗和/或预防人或非人哺乳动物心血管疾病的方法,其包括对有需要的人或非人哺乳动物施用有效的无毒量的式 (I)化合物:其中A 1表示取代或未取代的芳族杂环基;(I)化合物或其互变异构形式和/或其药物可接受的盐和/或其药学上可接受的溶剂化物, R1表示氢原子,烷基,酰基,芳烷基,其中芳基部分可以是取代或未取代的,或取代或未取代的芳基; R2和R3各自表示氢,或R2和R3一起表示键; A2代表总共有五个取代基的苯环; n表示2〜6的整数。

    Heterocyclic compounds useful as .alpha..sub.2 -adrenoceptor antagonists
    2.
    发明授权
    Heterocyclic compounds useful as .alpha..sub.2 -adrenoceptor antagonists 失效
    可用作α2-肾上腺素受体拮抗剂的杂环化合物

    公开(公告)号:US5310750A

    公开(公告)日:1994-05-10

    申请号:US663393

    申请日:1991-03-01

    CPC分类号: C07D403/06

    摘要: A compound of formula (I): ##STR1## or a pharmaceutically acceptable salt thereof, wherein: R.sup.1 and R.sup.2 may each represent hydrogen or alkyl providing that at least one of R.sup.1 or R.sup.2 represents alkyl;R.sup.3 and R.sup.4 each represent hydrogen or R.sup.3 and R.sup.4 together represent a bond;n represents an integer 1 or 2;and m represents an integer 1 or 2; a composition containing such a compound and the method of using such compounds and compositions in medicine.

    摘要翻译: 式(I)的化合物:其中R 1和R 2可以各自表示氢或烷基,条件是R 1或R 2中的至少一个表示烷基; R3和R4各自表示氢或R3和R4一起表示键; n表示整数1或2; m表示整数1或2; 含有这种化合物的组合物和在医药中使用这些化合物和组合物的方法。

    Treatment for hyperglycaemia
    3.
    发明授权
    Treatment for hyperglycaemia 失效
    治疗高血糖

    公开(公告)号:US5141933A

    公开(公告)日:1992-08-25

    申请号:US588354

    申请日:1990-09-26

    摘要: A method for the treatment and/or prophylaxis of hyperglycaemia in human or non-human mammals which comprises administering to the mammal in need of such treatment and/or prophylaxis an effective non-toxic amount of: a compound of formula (I): ##STR1## or a pharmaceutically acceptable acid additon salt thereof, wherein each of R.sup.1 and R.sup.2, which may be the same or different, represents a hydrogen or haolgen atom, or an alkyl or alkoxy group containing 1 to 4 carbon atoms, X represents an oxygen or sulphur atom, an imino group, an acylimino group containing 2 to 4 carbon atoms in the acyl group, or a methylene group, each of n and m, which may be the same or different, represents the number 1, 2 or 3, and p represents the number 2 or 3.

    摘要翻译: 一种用于治疗和/或预防人或非人哺乳动物高血糖症的方法,其包括对需要这种治疗和/或预防有效无毒量的哺乳动物施用:式(I)化合物: IMAGE>(I)或其药学上可接受的酸加成盐,其中R 1和R 2可以相同或不同,表示氢或氢原子,或含有1至4个碳原子的烷基或烷氧基,X 代表氧或硫原子,酰亚胺基,酰基中含有2至4个碳原子的酰亚胺基或亚甲基,n和m各自可以相同或不同,表示数字1,2 或3,p表示数字2或3。